Tongjitang Chinese Medicines Co. Google Group

EXPLODING STOCK PICK SOLVING THE FUTURE ENERGY CRISIS WWPW @ http://www.stockexploder.com

bbballard...@gmail.com (Ballard Ballard) — Mon, 02 Nov 2009 05:14:15 UT

Dear Friends:

Here is our New Exploding Stock Pick -WWPW IS GOING TO DOMINATE THE
FUTURE

WIND WORKS POWER (WWPW) THE FUTURE OF ENERGY [link]

WWPW LIST OF GREAT PROJECTS [link]

U.S. DEPARTMENT OF ENERGY Wind Energy Could Produce 20 Percent of U.S.

Positive data from the Phase 2 trial of ISIS’s diabetes drug

sudipbanerjeeos...@gmail.com (babu) — Sat, 24 Oct 2009 10:53:43 UT

Isis Pharmaceuticals Inc (ISIS) recently reported that its
experimental diabetes drug, ISIS 113715, showed consistent and
statistically significant reduction in glucose levels in a mid-stage
trial. To read more details about the drug and its market potential,
read a FREE report on ISIS 113715 at: [link]

FDA delayed the approval of Fampridine SR

daspinky2...@gmail.com (pinky das) — Fri, 23 Oct 2009 12:38:05 UT

The FDA has delayed the approval decision of Acorda Therapeutics
Inc.’s (ACOR) Fampridine SR for the treatment of walking disability
associated with multiple sclerosis (MS) till January 22, 2010. To
read about the event, go to report available for FREE at
[link]

Upcoming FDA decision of a small-cap company’s drug for walking disability associated with multiple sclerosis on October 22

ritushre...@gmail.com (ritushreeya) — Tue, 29 Sep 2009 12:42:20 UT

The FDA will make a decision on the approval of a small-cap company’s
drug for walking disability associated with multiple sclerosis on
October 22. If approved, this could become a breakthrough treatment
for walking disability associated with multiple sclerosis. To find
out what the chances are of this new drug being approved, how the drug

美股价值投资讨论群

chen...@gmail.com (calvin) — Thu, 17 Sep 2009 07:57:34 UT

我创建了一个专门用于讨论美股基本面的QQ群:89851125 。希望广大热衷于价值投资的朋友加入进来，共同探讨，共同提高。如果你以技术分析为自
己的投资依据，请寻找其它适合你的群组，如果你是听消息，凭感觉，看不懂财务报表的人，请过几年再来。相信每个人基于自己所在行业及对周围

FDA decision regarding approval of an Opthalmic (eye) drug is coming soon.

tanumoydutta1...@gmail.com (tanu) — Wed, 02 Sep 2009 12:13:34 UT

The FDA will be review a new drug in the opthalmic (eye) area on
September 12th. If this drug gets the FDA approval, the stock could
see a substantial increase in valuation because the estimated Peak
Sales of the drug compared to its current market capitalization is at
approximately 70%. To read about which company, what drug, which

A FREE report on the approval of a new Gout Drug

sudipbanerjeeos...@gmail.com (babu) — Thu, 30 Jul 2009 12:14:28 UT

An upcoming treatment by a small cap company for Gout to face FDA
decision on approval shortly. Gout has traditionally been a difficult
disease to treat. To read about whether this small cap company has
chances to get their drug approved, get a FREE report at our website:
NEWBIOMEDICINE.COM

Free report on upcoming FDA panel decision of Corvue on Tuesday

sudipbanerjee.an...@gmail.com (sudip) — Tue, 28 Jul 2009 12:04:14 UT

FDA Panel to review this Biotech company's stress agent drug on July
28th. If they get a favorable backing by the panel, the chances of
approval by the FDA will increase significantly. If the drug gets
approved by the FDA, it is estimated to achieve Peak sales of $350
million. To read about our expectation on the Panel decision, the

Upcoming FDA panel decision on Corvue next week

sudipbanerjee.an...@gmail.com (sudip) — Sat, 25 Jul 2009 12:15:09 UT

upcoming event analysis on FDA panel for Corvue

sudipbanerjeeos...@gmail.com (babu) — Fri, 24 Jul 2009 12:16:51 UT

Upcoming FDA Panel decision on Biotech company's stress agent drug on July 28th,get the FREE report at: NEWBIOMEDICINE.COM

sudipbanerjeeos...@gmail.com (babu) — Thu, 23 Jul 2009 12:35:13 UT

Upcoming FDA Decision on approval of a small cap company's drug to treat Gout

lopa86...@gmail.com (lopamudra) — Mon, 20 Jul 2009 12:12:07 UT

A small cap company’s upcoming Phase 2 Alzheimer's drug data presentation next week

daspinky2...@gmail.com (pinky das) — Fri, 10 Jul 2009 11:57:52 UT

A small cap company is going to be presenting data on their
Alzheimer's drug at the Alzheimer's conference next week. If the
trials data is positive, it brings the company one step closer to the
approval of a breakthrough treatment for Alzheimer's disease. To find
out about the company, the drug, how the drug works, who are the other

A small cap company's upcoming Phase 2 arthritis drug data on July 9th (Thursday)

dasamrit...@yahoo.com (amritadas) — Thu, 09 Jul 2009 11:20:37 UT

A small cap company is going to be presenting data on its arthritis
drug on July 9th (Thursday). If the trials data is positive, it
brings the company one step closer to the approval of a promising
treatment for arthritis. Given the size of the arthritis disease
market, this could result in a significant movement in the stock

Get a FREE report on upcoming clinical trial data presentation of a small cap company's Alzheimer's drug in next week

dasamrit...@yahoo.com (amritadas) — Wed, 08 Jul 2009 12:05:23 UT